Possible involvement of advanced glycation end products in periodontal diseases

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 3, 2010, Pages 683-691

  Pietropaoli, D ^a   Tatone, C ^a   D'Alessandro, A M ^a   Monaco, Annalisa ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Advanced glycation end products; AGE; Oxidative stress; Periodontal diseases; Periodontal ligament; ROS

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR;

DISEASE SEVERITY; HUMAN; INFLAMMATION; OXIDATIVE STRESS; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVIEW;

EID: 78149256393     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300301     Document Type: Review

References (50)

1. Wouter Beertsen CA, Mcculloch G, Sodek J. The periodontal ligament: a unique, multifunctional connective tissue. Periodontology 2000; 1997;13:20-40.
2. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontology 2000; 71:156-63.
3. Hutter EA, Machado DC, de Oliveira RB, et al. Effects of human aging on periodontal tissues. Spec Care Dentist 2009; 29:149-55.
4. Ohi T, Uehara Y, Takatsu M, Watanabe M, Ono T. Hypermethylation of CpGs in the promoter of the COL1A1 gene in the aged periodontal ligament. J Dent Res 2006; 85:245-50.
5. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000; 13:547-58.
6. Noack B, Jachmann I, Roscher S, Sieber L, Kopprasch S, Lück C, Hanefeld M, Hoffmann T. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 2000; 71:898-903.
7. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993; 16:329-34.
8. Morita T, Ogawa Y, Takada K, Nishinoue N, Sasaki Y, Motohashi M, Maeno M. Association between periodontal disease and metabolic syndrome. J Public Health Dent, Lion Foundation for Dental Health, Japan, 2009; 69:248-253.
9. Aukhil I, Nishimura K, Fernyhough W. Experimental regeneration of the periodontium. Crit Rev Oral Biol Med 1990; 1:101-15.
10. Ballini A, De Frenza G, Cantore S, Papa F, Grano M, Mastrangelo F, Tetè S, Grassi FR. In vitro stem cell cultures from human dental pulp and periodontal ligament: new prospects in dentistry. Int J Immunopathol Pharmacol 2007; 20:9-16.
11. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001; 56:1-21.
12. Tatone C, Carbone MC, Campanella G, Festuccia C, Artini PG, Talesa V, Focarelli R, Amicarelli F. Female reproductive dysfunction during aging: role of methyglyoxal in the formation of AGEs in ovaries of reproductively aged mice. J Biol Regul Homeost Agents 2010; 24:63-72.
13. Schmidt AM, Weidman E, Lalla E, Yan SD, Hori O, Cao R, Brett JG, Lamster IB. Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996; 31:508-15.
14. Peppa M, Uribarri J, Vlassara H. Aging and glycoxidant stress. Hormones 2008; 7:123-32.
15. Thornalley PJ. Dicarbonyl intermediates in the maillard reaction. Ann NY Acad Sci 2005; 1043:111-17.
16. Baynes JW. The role of AGEs in aging: causation or correlation. Exp Gerontol 2001; 36:1527-37
17. Zhang Q, Ames JM, Smith RD, Baynes JW, Metz TO. A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease. J Proteome Res 2009; 8:754-69.
18. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 2000; 275:39027-31.
19. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005; 15:16R-28R.
20. Schmidt AM, Stern DM. Hyperinsulinemia and vascular dysfunction: the role of nuclear factor-kappaB, yet again. Circ Res 2000; 87:722-4.
21. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240:1546-8.
22. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell, 1999; 97:889-901.
23. Soldatos G, Cooper ME. Advanced glycation end products and vascular structure and function. Curr Hypertens Rep 2006; 8:472-8.
24. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289:F645-59.
25. Needleman IG, Worthington HV, Giedrys-Leeper E, Tucker RJ. Guided tissue regeneration for periodontal infra-bony defects. Cochrane Database Syst Rev 2006
26. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007; 43:160-232.
27. Tsai CC, Chen HS, Chen SL, Ho YP, Ho KY, Wu YM, Hung CC. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005; 40:378-84.
28. Lee YS, Bak EJ, Kim M, Park W, Seo JT, Yoo YJ. Induction of IL-8 in periodontal ligament cells by H(2)O(2). J Microbiol 2008; 46:579-84.
29. Soory M. Redox status in periodontal and systemic inflammatory conditions including associated neoplasias: antioxidants as adjunctive therapy? Infect Disord Drug Targets 2009; 9:415-27.
30. Bagaitkar J, Williams LR, Renaud DE, Bemakanakere MR, Martin M, Scott DA, Demuth DR. Tobacco-induced alterations to Porphyromonas gingivalis-host interactions. Environ Microbiol 2009; 11:1242-53.
31. Amaral Cda S, Vettore MV, Leão A. The relationship of alcohol dependence and alcohol consumption with periodontitis: a systematic review. J Dent 2009; 37:643-51.
32. Hujoel P. Dietary carbohydrates and dental-systemic diseases. J Dent Res 2009; 88:490-502.
33. Chapple IL. Potential mechanisms underpinning the nutritional modulation of periodontal inflammation. J Am Dent Assoc 2009; 140:178-84.
34. Covani U, Marconcini S, Derchi G, Barone A, Giacomelli L. Relationship between human periodontitis and type 2 diabetes at a genomic level: a data-mining study. J Periodontol 2009; 80:1265-73.
35. Allen EM, Matthews JB, O'Connor R, O'Halloran D, Chapple IL. Periodontitis and type 2 diabetes: is oxidative stress the mechanistic link? Scott Med J 2009; 54:41-7.
36. Nunn ME. Understanding the etiology of periodontitis: an overview of periodontal risk factors. Periodontol 2000 2003; 32:11-23.
37. Szczepański M, Kamianowska M, Skrzydlewska E. The influence of hyperglycemia on oxidation-reduction reaction of human umbilical vein endothelial cells. Pol Merkur Lekarski 2007; 23:246-50.
38. Hollá LI, Kanková K, Fassmann A, Bucková D, Halabala T, Znojil V, Vaněk J. Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: a preliminary study. J Periodontol 2001; 72:1742-6.
39. Murillo J, Wang Y, Xu X, Klebe RJ, Chen Z, Zardeneta G, Pal S, Mikhailova M, Steffensen B. Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior. J Periodontal 2008; 79:2190-9.
40. Ren L, Fu Y, Deng Y, Qi L, Jin L. Advanced glycation end products inhibit the expression of collagens type I and III by human gingival fibroblasts. J Periodontol 2009; 80:1166-73.
41. Steffensen B, Häkkinen L, Larjava H. Proteolytic events of wound-healing - coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 2001; 12:373-98.
42. Lackler KP, Cochran DL, Hoang AM, Takacs V, Oates TW. Development of an in vitro wound healing model for periodontal cells. J Periodontol 2000; 71:226-37.
43. Hayashida H, Kawasaki K, Yoshimura A, et al. Relationship between periodontal status and HbA1c in non-diabetics. J Public Health Dent 2009; 69:204-6.
44. Dangaria SJ, Ito Y, Walker C, Druzinsky R, Luan X, Diekwisch TG. Extracellular matrix-mediated differentiation of periodontal progenitor cells. Differentiation 2009; 78:79-90.
45. Metz TO, Alderson NL, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch Biochem Biophys 2003; 419:41-9.
46. Beisswenger P, Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab 2003; 29:95-103.
47. Yamagishi S. Calcium antagonist: current and future applications based on new evidence. Calcium antagonists and diabetes. Clin Calcium 2010; 20:77-82.
48. Soory M. A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases: a literature review. Open Dent J 2008; 2:5-12.
49. Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, Genco RJ. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997; 68:713-9.
50. Martorelli de Lima AF, Cury CC, Palioto DB, Duro AM, da Silva RC, Wolff LF. Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. J Clin Periodontol 2004; 31:648-53.